Taking medication
How things change, what is normal, and the two-blood-test rhythm that we use to tune the dose.
LoveMyLife Andropause team
MRCGP-led, endocrinology-overseen
22 April 2026
6 min read

The first twelve weeks on testosterone replacement therapy are different from what most men expect. The changes are real but slower than you might hope, not always in the order you expect, and the blood work needs tuning rather than set-and-forget. This article describes the realistic timeline and what we do at each check-in.
First prescription goes out after the full assessment, baseline bloods are in, and we have agreed the delivery form. For most patients that means a starting dose of Testogel 50mg daily, or Nebido 1000mg intramuscular, or testosterone enanthate 125mg weekly self-injected.
Whatever the form, the first application or injection raises your testosterone over hours to days. The biological effect comes over weeks. Do not expect transformation in the first few days.
The earliest change that men notice is usually mood or energy. Many report feeling clearer, more motivated, or simply "like myself" within 10 to 14 days. This is real but subjective and can be partly placebo.
Libido sometimes shifts in the first fortnight. Morning erections may return. This is the first functional sign that the treatment is taking hold.
Physical changes are still minimal. Muscle and fat changes are weeks to months away.
What to watch for: injection-site reactions if injecting, skin irritation if on gel, early headache or fluid retention. None of these is alarming in the first fortnight but worth flagging at the week-4 review if persistent.
We check in at four weeks. Usually a 15-minute consultation by video to review how it is going, any side effects, mood, sleep, sexual function. No bloods yet; too early.
Common at four weeks: improvements in libido and energy; no visible body composition changes yet; occasional mild headache or fluid retention; skin oiliness returning (if you had acne as a teenager, hello again).
Not normal at four weeks: severe headache, significant mood deterioration, chest pain, breathlessness, painful injection-site swelling lasting more than a few days. These trigger an immediate clinical review.
Things usually smooth out during this period. Energy and mood stabilise. Libido continues to improve. Morning erections become more reliable. Some men notice sleep changes: usually better, occasionally worse due to increased metabolic rate or sometimes unmasking of apnoea we had not caught.
Body composition changes start to be noticeable around week 6 to 8. Muscle feels slightly denser under the skin; abdominal fat feels slightly softer. Nothing dramatic yet, but the trajectory is set.
Some men develop mild gynaecomastia tenderness around week 6 to 8 due to rising E2. This is not uncommon and usually settles once we adjust the dose or add a low-dose aromatase inhibitor if needed.
The most important assessment point. Full repeat bloods: total T, free T, SHBG, E2, haematocrit, PSA, lipids, LFTs. Consultation to review results and talk about the subjective experience.
What we are looking for: total T in the mid-normal range (ideally 15 to 25 nmol/L on trough testing for injections, or stable in mid-range for gels), haematocrit not significantly raised, E2 not disproportionately elevated, PSA stable, lipids stable, no liver concern.
Common adjustments at 12 weeks: dose increase if T is still low-normal and symptoms are not fully resolved (perhaps 30 percent of patients), dose decrease if T is supraphysiological (rare, perhaps 10 percent), E2 management if gynaecomastia or water retention is prominent, haematocrit monitoring if it has risen fast.
If everything is in order, we continue at the current dose and the next review is at 6 months.
By three months, most men on an appropriately titrated regimen report:
- Libido close to where it was before hypogonadism began - Morning erections reliable most mornings - Erectile function improved (sometimes needing PDE5 support for fine-tuning) - Energy and mood substantially improved - Sleep better (unless underlying apnoea has been unmasked or worsened) - Gym performance slightly improved with modest muscle gain - Visceral fat softening, particularly with concurrent lifestyle work - General sense of wellbeing and motivation better
What has not changed much yet: body composition in dramatic terms. Muscle hypertrophy requires not just TRT but resistance training and adequate protein intake; this plays out over 6 to 12 months. Bone mineral density takes even longer (meaningful changes at 12 to 24 months).
During the 4 to 12 week window, our monitoring relies on messaging, symptom diaries, and red-flag watching. Specific things we ask about:
- Sleep quality and duration - Mood stability - Libido and erectile function - Injection or gel tolerance - Any unusual chest or leg symptoms (tiny but real concern for haematocrit / DVT) - Weight, waist measurement, gym performance (subjective, weekly)
A symptom diary is not mandatory but is helpful. Some men like a simple weekly 1 to 10 rating of energy, mood, libido, and sleep. This makes dose tuning conversations more efficient.
Usually we wait for the 12-week bloods to adjust dose. The exceptions: clear supraphysiological response on repeat early testing, clear side effect pattern that is dose-related (severe acne, rapid haematocrit rise, significant mood destabilisation), or if we started you at a cautious low dose pending early response.
Most men stay on their starting dose through to 12 weeks even if subjective response is partial. The kinetics need that long to settle.
The typical patient who turns out to be a good responder reports steady weekly-to-monthly improvement through weeks 2 to 10, then a sense that things have plateaued around weeks 10 to 14, then the 12-week bloods confirm the dose is right and the next improvements come from concurrent lifestyle work (sleep, training, diet).
About 15 percent of men are slower responders who need until 16 to 20 weeks to feel their full benefit. A small number (5 to 10 percent) are non-responders to the starting regimen and need a dose increase, a form switch, or a reconsideration of whether TRT is the right treatment.
The first 12 weeks sets the baseline. Most of the adjustment work happens at the 12-week mark based on bloods plus symptoms. By 6 months on a stable dose, the trajectory of benefits is usually clear and long-term planning is straightforward.
Clinically reviewed
Dr Seth Rankin · MBChB MRCGP - Founder and Medical Director, LoveMyLife
5 services
If this article has made you think an assessment might help, the next step is a short consultation with one of our men's health doctors.
Begin your consultation at this link. Online or in person at Westfield London.